Addition of pTau217 test further expands the company's leadership in testing options for Alzheimer's disease to improve patient care Alzheimer's disease, the most prevalent form of dementia, poses a ...
While a blood test to look for Alzheimer’s is a monumental leap, and is a great source of hope, we need to remember that a ...
The laboratory-developed test, named AD-Detect™ Abeta 42/40 and p-tau217 Evaluation, combines results of blood levels of amyloid beta (AB) 42/40 determined by the company's proprietary tandem mass ...
As the world’s population ages, health experts are bracing for higher rates of age-related diseases, including Alzheimer’s. Finding new ways to diagnose the condition is more of a priority than ever, ...
Division Director: Sixto Leal, M.D., Ph.D. The second-largest clinical division in the Department of Pathology after Anatomic Pathology, Laboratory Medicine engages in clinical service, oversight of ...
NEW YORK--(BUSINESS WIRE)--Alliance Laboratories, an independent full-service laboratory founded in June of 2000, has announced the milestone of delivering over 20 million test results to patients and ...
In an oral presentation at the 2025 AAN Annual Meeting, Quest scientists presented data suggesting the test can accurately assess Alzheimer's disease pathology with greater than 90% sensitivity and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback